These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 2548531)

  • 1. Effects of opiate antagonists and their quaternary analogues on nucleus accumbens self-stimulation.
    Trujillo KA; Belluzzi JD; Stein L
    Behav Brain Res; 1989 Jun; 33(2):181-8. PubMed ID: 2548531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of opioid antagonists and their quaternary derivatives on locomotor activity and fixed ratio responding for brain self-stimulation in rats.
    Schaefer GJ; Michael RP
    Pharmacol Biochem Behav; 1985 Nov; 23(5):797-802. PubMed ID: 4080766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opiate antagonists and self-stimulation: extinction-like response patterns suggest selective reward deficit.
    Trujillo KA; Belluzzi JD; Stein L
    Brain Res; 1989 Jul; 492(1-2):15-28. PubMed ID: 2752295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of opiate antagonists and their quaternary derivatives on heroin self-administration in the rat.
    Koob GF; Pettit HO; Ettenberg A; Bloom FE
    J Pharmacol Exp Ther; 1984 May; 229(2):481-6. PubMed ID: 6716270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Central, stereoselective receptors mediate the acute effects of opiate antagonists on luteinizing hormone secretion.
    Blank MS; Mann DR; Daugherty DT; Sridiran R; Murphy JR
    Life Sci; 1986 Oct; 39(17):1493-99. PubMed ID: 3020332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-Methylated naloxone, naltrexone, oxymorphone, and their 14-O-methyl ethers.
    Schmidhammer H; Leander JD; Mayer-Valkanover K; Nussbaumer C; Schmidt C; Schoepp DD; Schratz A; Walla-Kugler M
    Prog Clin Biol Res; 1990; 328():41-4. PubMed ID: 2154800
    [No Abstract]   [Full Text] [Related]  

  • 7. Irreversible opiate agonists and antagonists. II. Evidence against a bivalent mechanism of action for opiate azines and diacylhydrazones.
    Hahn EF; Nishimura S; Goodman RR; Pasternak GW
    J Pharmacol Exp Ther; 1985 Dec; 235(3):839-45. PubMed ID: 2416909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opiate antagonists inhibit feeding induced by 8-OH-DPAT: possible mediation in the nucleus accumbens.
    Fletcher PJ
    Brain Res; 1991 Sep; 560(1-2):260-7. PubMed ID: 1836972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracranial self-administration of the endocoid methionine-enkephalin.
    Goeders NE; Smith JE; Lane JD
    J Am Osteopath Assoc; 1984 Sep; 84(1 Suppl):148-51. PubMed ID: 6092304
    [No Abstract]   [Full Text] [Related]  

  • 10. Blockade of nucleus accumbens opiate receptors attenuates intravenous heroin reward in the rat.
    Vaccarino FJ; Bloom FE; Koob GF
    Psychopharmacology (Berl); 1985; 86(1-2):37-42. PubMed ID: 2991967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of opiate antagonist treatment into either the periaqueductal grey or nucleus accumbens on heroin-induced locomotor activation.
    Vaccarino FJ; Corrigall WA
    Brain Res Bull; 1987 Nov; 19(5):545-9. PubMed ID: 3690365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of the effects of opiate antagonists infused into the nucleus accumbens on feeding and sucrose drinking in rats.
    Kelley AE; Bless EP; Swanson CJ
    J Pharmacol Exp Ther; 1996 Sep; 278(3):1499-507. PubMed ID: 8819538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antagonist treatment in nucleus accumbens or periaqueductal grey affects heroin self-administration.
    Corrigall WA; Vaccarino FJ
    Pharmacol Biochem Behav; 1988 Jun; 30(2):443-50. PubMed ID: 3174777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opiate antagonists: central sites of action in suppressing water intake of the rat.
    Brown DR; Holtzman SG
    Brain Res; 1981 Sep; 221(2):432-6. PubMed ID: 7284781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quaternary narcotic antagonists' relative ability to prevent antinociception and gastrointestinal transit inhibition in morphine-treated rats as an index of peripheral selectivity.
    Bianchi G; Fiocchi R; Tavani A; Manara L
    Life Sci; 1982 May; 30(22):1875-83. PubMed ID: 7109826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opposite effects of mu and kappa opiate agonists on dopamine release in the nucleus accumbens and in the dorsal caudate of freely moving rats.
    Di Chiara G; Imperato A
    J Pharmacol Exp Ther; 1988 Mar; 244(3):1067-80. PubMed ID: 2855239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Melatonin modifies prolactin release induced by opiate antagonists in male rats.
    Shacoori V; Saiag B; Rault B
    Endocr Res; 1995 Aug; 21(3):545-53. PubMed ID: 7588425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quaternary opiate antagonists lower blood pressure and inhibit leucine-enkephalin responses.
    Giles T; Sander G; Merz H
    Eur J Pharmacol; 1983 Nov; 95(3-4):247-52. PubMed ID: 6197313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-nociceptive effect of neuropeptide Y in the nucleus accumbens of rats: an involvement of opioid receptors in the effect.
    Li Y; Li JJ; Yu LC
    Brain Res; 2002 Jun; 940(1-2):69-78. PubMed ID: 12020877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of a peripheral and a central acting opioid antagonist on the testicular response to stress in rats.
    Akinbami MA; Taylor MF; Collins DC; Mann DR
    Neuroendocrinology; 1994 Apr; 59(4):343-8. PubMed ID: 8202214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.